New data suggests the weight-loss drug Wegovy may significantly reduce the risk of heart disease even before users experience ...

Q1 2025 Earnings Call Transcript May 11, 2025 Operator: Good day, ladies and gentlemen, and welcome to the LivaNova PLC First Quarter 2025 Earnings Conference Call. My name is Emily, and I’ll be ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...

Within six months, the drug reduced the risk of cardiovascular death by 50 and cut the risk of needing urgent treatment due to heart failure.

Harmony Biosciences Holdings, Inc. ( NASDAQ: HRMY) Q1 2025 Earnings Call May 6, 2025 8:30 AM ET Brennan Doyle - Head, Investor Relations Jeffrey Dayno - President and Chief Executive Officer Adam ...

Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsMercedes Carrasco - Senior Director ...

Patients, design and setting: 431 patients with osteoarthritis of the knee were enrolled in this randomised, double-blind, multicentre, parallel study. After titration to optimum dose (range 100 ...

This parallel-group dose titration study thus reflects clinical practice for initiating monotherapy for the treatment of essential hypertension.

Accordingly, we have designed a double-blinded placebo-controlled trial of daily LDN ... and dispensed at the C&W Pharmacy where the blinding will occur. The dose-titration schedule from 1 mg to 4.5 ...

Alec Burleson hit a two-run double, Matthew Liberatore struck out eight in a season-high seven innings and the St. Louis Cardinals beat the Pittsburgh Pirates 2-1 on Tuesday night.Liberatore (3-3 ...

As cars and trucks continuously pass on the bridge just a few yards behind the diamond, Jacob Powell’s infield chatter from shortstop rises above the din. Behind the dish, Chris Powell tries to ...

These dividend-paying companies have proven their mettle through challenging times. PepsiCo recently raised its payout by 5%, marking 53 straight annual increases. Shoppers remain drawn to Target ...